Literature DB >> 25374270

The impact of surgical resection of giant supratentorial brain tumor in pediatric patients: safety and neurological outcome evaluated in 23 consecutive cases.

Ricardo Santos de Oliveira1, Danilo Jorge Pinho Deriggi, Luciano L Furlanetti, Marcelo Volpon Santos, Elvis Terci Valera, Maria Sol Brassesco, Hélio Rubens Machado.   

Abstract

OBJECTIVE: This study aims to evaluate the impact of gross total resection of giant supratentorial brain tumors (GSBT) on survival and neurological outcome in a consecutive single-center pediatric series.
METHODS: Clinical data of 23 patients under 18 years of age operated with GSBT (≥5 cm in diameter) were reviewed to determine epidemiological aspects, clinical presentation, associated factors, histopathological features, and outcome. Volumetric measurements were performed on magnetic resonance imaging or computed tomography scans obtained at the time of the initial surgical procedure.
RESULTS: The group included 23 patients (mean age 4.5 years). Signs and symptoms of raised intracranial pressure were present in 19 patients (82.6%). The most frequent tumor location was the parietal lobe in 19 patients (82.6%), and the mean tumor volume was 208 cm(3). Gross total or radical resection was achieved in all patients. Histopathological analysis revealed malignant brain tumors in 18 cases (78.2%). The most common neoplasm was choroid plexus carcinoma in seven (30.4 %). Mean intraoperative blood transfusion volume was 51.2 ml/kg. Chemotherapy and/or radiotherapy were performed as adjuvant treatment in 16 patients (69.5%). Mean length of follow-up was 36.7 months. Tumor malignancy grade significantly correlated with recurrence of the disease (P = 0.03) and death (P = 0.01), as opposed to tumor location, size, and extension to the ventricles.
CONCLUSIONS: Our clinical experience suggests that tumor mass reduction by en bloc surgery seems to be an effective approach in pediatric patients with GSBT, relieving symptoms related to raised intracranial pressure and providing a better response to adjuvant treatment.

Entities:  

Mesh:

Year:  2014        PMID: 25374270     DOI: 10.1007/s00381-014-2583-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  35 in total

1.  Brain tumors in the first three years of life: a review of twenty cases.

Authors:  Adriana Avila de Espíndola; Hamilton Matushita; Juliana Martins Pimenta; Ana Cristina da Silva Fernandes; Sérgio Rosemberg; Umbertina Conti Reed
Journal:  Arq Neuropsiquiatr       Date:  2007-12       Impact factor: 1.420

2.  Resection of infantile brain tumors after neoadjuvant chemotherapy: the St. Jude experience.

Authors:  Mark Van Poppel; Paul Klimo; Mariko Dewire; Robert A Sanford; Frederick Boop; Alberto Broniscer; Karen Wright; Amar J Gajjar
Journal:  J Neurosurg Pediatr       Date:  2011-09       Impact factor: 2.375

3.  Brain tumors in children under 3 years of age. Recent experience (1987-1997) in 39 patients.

Authors:  F Sala; E Colarusso; C Mazza; A Talacchi; A Bricolo
Journal:  Pediatr Neurosurg       Date:  1999-07       Impact factor: 1.162

Review 4.  The therapy of infantile malignant brain tumors: current status?

Authors:  Chantal Kalifa; Jacques Grill
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

5.  Choroid plexus tumors in children less than 36 months: the Canadian Pediatric Brain Tumor Consortium (CPBTC) experience.

Authors:  Lucie Lafay-Cousin; Daniel Keene; Anne-Sophie Carret; Chris Fryer; Josee Brossard; Bruce Crooks; David Eisenstat; Donna Johnston; Valerie Larouche; Marianna Silva; Beverly Wilson; Shayna Zelcer; Ute Bartels; Eric Bouffet
Journal:  Childs Nerv Syst       Date:  2010-08-31       Impact factor: 1.475

Review 6.  Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors.

Authors:  Patricia K Duffner
Journal:  Neurologist       Date:  2004-11       Impact factor: 1.398

7.  Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.

Authors:  Roger J Packer; Tianni Zhou; Emi Holmes; Gilbert Vezina; Amar Gajjar
Journal:  Neuro Oncol       Date:  2012-10-25       Impact factor: 12.300

8.  Functional motor recovery of an infant after a huge ependymoma resection.

Authors:  Tatsuya Abe; Tohru Kamida; Yasutomo Momii; Mitsuhiro Anan; Hiroshi Ooba; Minoru Fujiki; Teruaki Mori
Journal:  Clin Neurol Neurosurg       Date:  2009-07-23       Impact factor: 1.876

Review 9.  Current management of choroid plexus carcinomas.

Authors:  Matthew Z Sun; Michael C Oh; Michael E Ivan; Gurvinder Kaur; Michael Safaee; Joseph M Kim; Joanna J Phillips; Kurtis I Auguste; Andrew T Parsa
Journal:  Neurosurg Rev       Date:  2013-09-26       Impact factor: 3.042

10.  Childhood choroid plexus papillomas: operative complications.

Authors:  Raj Kumar; Surendra Singh
Journal:  Childs Nerv Syst       Date:  2004-08-12       Impact factor: 1.475

View more
  3 in total

1.  Clinicopathological features and microsurgical outcomes for giant pediatric intracranial tumor in 60 consecutive cases.

Authors:  Ailing Guo; Vigneyshwar Suresh; Xianzhi Liu; Fuyou Guo
Journal:  Childs Nerv Syst       Date:  2017-02-08       Impact factor: 1.475

Review 2.  Perinatal (fetal and neonatal) choroid plexus tumors: a review.

Authors:  John R Crawford; Hart Isaacs
Journal:  Childs Nerv Syst       Date:  2019-04-05       Impact factor: 1.475

3.  Giant Pediatric Supratentorial Tumor: Clinical Feature and Surgical Strategy.

Authors:  Zhong-Ding Zhang; Huang-Yi Fang; Chen Pang; Yue Yang; Shi-Ze Li; Ling-Li Zhou; Guang-Hui Bai; Han-Song Sheng
Journal:  Front Pediatr       Date:  2022-04-26       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.